RxDoctor Payments Data

Michael Yoon, MD

Family Medicine · Middleton, MANPI 1790761294

Payments from drug & device makers

$727in general payments, 2019–2025

Across 18 payments — averaging $40.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Choice Spine, LLC$172
  • Highridge Medical LLC$129
  • EBI, LLC$129
  • Boehringer Ingelheim$58
  • Amgen$58
  • GSK$36
  • plus $144 from 8 others

What the payments were for

  • Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$727 in reported general payments places this provider in the 80th percentile of 1,049 family medicine providers in Massachusetts.

See all family medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$354,767
Medicare patients
1,154
Services billed
7,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban161$131,888
AtivanLorazepam11$55,996
OxycontinOxycodone Hcl51$46,025
TrulicityDulaglutide26$35,608
JardianceEmpagliflozin35$31,920
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$26,802
OzempicSemaglutide20$19,375
XareltoRivaroxaban12$17,788
SymbicortBudesonide/Formoterol Fumarate57$14,962
Spiriva HandihalerTiotropium Bromide17$8,622
Omeprazole300$6,169
VascepaIcosapent Ethyl17$6,107
Breo ElliptaFluticasone/Vilanterol21$5,970
Atorvastatin Calcium434$5,909
Oxycodone Hcl383$5,159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$131,888161 claims
Lilly USA, LLCTrulicity$15$35,60826 claims
GSKTrelegy Ellipta, Breo Ellipta$36$32,77259 claims
Boehringer IngelheimJardiance$58$31,92035 claims
AstraZenecaSymbicort, Pulmicort Flexhaler$15$18,05068 claims
Johnson & JohnsonXarelto$15$17,78812 claims
AbbVieSynthroid$23$1,78417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,049 family medicine providers in Massachusetts.

Other family medicine in Middleton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →